AlphaOnco Swiss has opened its new office in Valais. Watch CEO Edouard Alphandery explain why he picked the BioArk technology site in Monthey for his business.
Switzerland remains a fantastic place to set up a business. In particular, many foreign companies from all over the world have decided to create a limited company or open a branch in Switzerland. Choosing the ideal location for a company is a crucial step in its development.
Valais – the ideal setting
The Swiss subsidiary of the French company Nanobactérie, AlphaOnco Swiss, decided to open its Swiss office in Monthey at the BioArk technology site dedicated to life sciences. It was a crucial decision for the company’s CEO, Edouard Alphandery. He explains: “Economic Promotion Valais played a key role in helping us with the administrative and legal aspects. Their help turned out to be essential in allowing us to quickly and effectively set up our operations in Switzerland.”
Find out more about AlphaOnco Swiss and why they picked Valais as their place of business in this video interview from the Greater Geneva Bern area.
At the heart of innovation in cancer treatments
AlphaOnco Swiss is developing a cancer treatment using natural minerals. They are introduced into tumours which are then heated by ultrasound. The company’s objective is to develop a treatment accessible to as many people as possible, in particular those suffering from prostate cancer. AlphaOnco Swiss aims to simplify treatment by avoiding hospitalisation, general anaesthetic and the operating theatre. This approach will be particularly beneficial for those with limited access to hospital care or when hospitals are overcrowded.
Source : GGBa